FAQs What purity level does your BPC-157 peptide meet
CHST14 EDS/musculocontractural EDS The features of this rare condition (MIM 601776) include progressive kyphoscoliosis, adducted thumbs in infancy, clubfoot, arachnodactyly, joint hypermobility, fragile and hyperextensible skin with atrophic scars and delayed wound healing.20 22 Arthrochalasic EDS Arthrochalasic EDS (MIM 130060) is extremely rare.23 Congenital bilateral hip dislocation, severe joint hypermobility with recurrent dislocations, skin hyperextensibility, easy bruising, atrophic scars, kyphoscoliosis and osteopaenia are the features of this autosomal-dominant condition
Regulatory Status BPC-157 is not an FDA-approved drug for any indication and has not been evaluated by the FDA for safety or efficacy
Mike brings more than just a medical perspective to his clients
and medicine for treating acute hepatic poisoning, ischemia from oxygen deprivation, and for accelerating recovery after surgery [223,224]